Dexcom (DXCM) Other Non-Current Assets (2010 - 2026)
Dexcom's (DXCM) quarterly Other Non-Current Assets came in at $273.7 million in Q2 2026, up 55.95% year-over-year from $175.5 million in Q2 2025, and down 4.27% quarter-over-quarter from $285.9 million in Q1 2026.
Analysis
Dexcom (DXCM) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Other Non-Current Assets for 17 consecutive years, with $273.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 55.95% year-over-year to $273.7 million in Q2 2026; TTM through Jun 2026 was $273.7 million, a 55.95% increase from a year earlier, with the FY2025 full-year figure at $278.7 million, up 61.1% from the prior year.
- Other Non-Current Assets was $273.7 million for Q2 2026 at Dexcom, down from $285.9 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $285.9 million in Q1 2026 and troughed at $22.8 million in Q1 2022.
- A 5-year average of $126.8 million and a median of $80.3 million in 2024 frame the typical range for Other Non-Current Assets.
- The widest YoY moves for Other Non-Current Assets: up 348.57% in 2022, down 6.44% in 2022.
- Over 5 years, Other Non-Current Assets stood at $47.1 million in 2022, then surged by 59.24% to $75.0 million in 2023, then jumped by 130.67% to $173.0 million in 2024, then soared by 61.1% to $278.7 million in 2025, then dropped by 1.79% to $273.7 million in 2026.
- The last three Other Non-Current Assets figures came in at $273.7 million (Q2 2026), $285.9 million (Q1 2026), and $278.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.62 Bn | 179.02 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.22 Bn | 119.01 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 104.98 Bn | 101.51 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 34.01 Bn | 32.56 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Zimmer Biomet Holdings | 18.23 Bn | 17.82 Bn | 1.54 Bn | 1.08 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 273.70 Mn |
| Mar 31, 2026 | 285.90 Mn |
| Dec 31, 2025 | 278.70 Mn |
| Sep 30, 2025 | 276.50 Mn |
| Jun 30, 2025 | 175.50 Mn |
| Mar 31, 2025 | 168.50 Mn |
| Dec 31, 2024 | 173.00 Mn |
| Sep 30, 2024 | 88.20 Mn |
| Jun 30, 2024 | 82.90 Mn |
| Mar 31, 2024 | 77.70 Mn |
| Dec 31, 2023 | 75.00 Mn |
| Sep 30, 2023 | 74.40 Mn |
| Jun 30, 2023 | 66.90 Mn |
| Mar 31, 2023 | 56.60 Mn |
| Dec 31, 2022 | 47.10 Mn |
| Sep 30, 2022 | 33.70 Mn |
| Jun 30, 2022 | 24.80 Mn |
| Mar 31, 2022 | 22.80 Mn |
| Dec 31, 2021 | 10.50 Mn |
| Jun 30, 2021 | 23.30 Mn |